Evaluating the Newly Proposed ARDS Definition in Hospitalized Patients With COVID-19 Treated With High-Flow Nasal Oxygen

被引:1
|
作者
Isha, Shahin [1 ]
Olaizola, Gustavo [2 ,3 ]
Bisso, Indalecio Carboni [2 ]
Raavi, Lekhya [1 ]
Jonna, Sadhana [1 ]
Jenkins, Anna [1 ]
Hanson, Abby [1 ]
Kashyap, Rahul [1 ,4 ]
Monzon, Veronica [5 ]
Huespe, Ivan A. [2 ,3 ]
Sanghavi, Devang [1 ]
机构
[1] Mayo Clin, Jacksonville, FL USA
[2] Hosp Italiano Buenos Aires, Buenos Aires, Argentina
[3] Univ Buenos Aires, Buenos Aires, Argentina
[4] Well Span Hlth, York, PA USA
[5] Hosp Italiano Agustin Roca, Buenos Aires, Argentina
关键词
ARDS; coronavirus disease 2019; high-flow nasal cannula oxygen; oxygen saturation; critical care; RESPIRATORY-DISTRESS-SYNDROME;
D O I
10.4187/respcare.11933
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: The new Global definition of ARDS recently introduced a subgroup known as non-intubated ARDS. This study aimed to assess the risk of progression from noninvasive oxygen support to intubation and ARDS severity based on the S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> among non-intubated subjects with ARDS. Methods: This retrospective study included subjects with COVID-19 admitted to 7 hospitals (5 in the United States and 2 in Argentina) from January 2020-January 2023. Subjects meeting the new non-intubated ARDS definition (high-flow nasal cannula [HFNC] with an S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 315 [with S<INF>pO<INF>2</INF></INF> <= 97%] or a P<INF>aO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 300 mm Hg while receiving >= 30 L/min O<INF>2</INF> via HFNC) were included. The study evaluated the proportion of subjects who progressed to intubation, severity levels using the S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> cutoff proposed in the new ARDS definition, and mortality. Results: Nine hundred sixty-five non-intubated subjects with ARDS were included, of whom 27% (n = 262) progressed to meet the Berlin criteria within a median of 3 d (interquartile range 2-6). The overall mortality was 23% (95% CI 20-26) (n = 225), and among subjects who progressed to the Berlin criteria, it was 37% (95% CI 31-43) (n = 98). Additionally, the worst S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> within 1 d of ARDS diagnosis was correlated with mortality, with mortality rates of 26% (95% CI 23-30) (n = 177) for subjects with S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 148, 17% (95% CI 12-23) (n = 38) for those with S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> between 149-234, and 16% (95% CI 8-28) (n = 10) for subjects maintaining an S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> higher than 235 (P < .001). Conclusions: The non-intubated ARDS criteria encompassed a broader spectrum of subjects with lower in-hospital mortality compared to the Berlin criteria. The S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> and ARDS severity cutoff proposed in the new Global ARDS definition were valuable predictors of in-hospital mortality in these subjects.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 50 条
  • [21] High-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19
    Panadero, Carolina
    Abad-Fernandez, Araceli
    Teresa Rio-Ramirez, Ma
    Acosta Gutierrez, Carmen Maria
    Calderon-Alcala, Mariara
    Lopez-Riolobos, Cristina
    Matesanz-Lopez, Cristina
    Garcia-Prieto, Fernando
    Maria Diaz-Garcia, Jose
    Raboso-Moreno, Beatriz
    Vasquez-Gambasica, Zully
    Andres-Ruzafa, Pilar
    Luis Garcia-Satue, Jose
    Calero-Pardo, Sara
    Sagastizabal, Belen
    Bautista, Diego
    Campos, Alfonso
    Gonzalez, Marina
    Grande, Luis
    Jimenez Fernandez, Marta
    Santiago-Ruiz, Jose L.
    Caravaca Perez, Pedro
    Jose Alcaraz, Andres
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2020, 15
  • [22] EFFICACY OF HIGH-FLOW NASAL CANNULA AND NONINVASIVE POSITIVE PRESSURE VENTILATION IN COVID-19 ARDS
    Madabhushi, Anirudh
    Roll, Brianna
    Wong, Steven
    Bagsic, Samantha
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 467 - 467
  • [23] High-flow nasal cannulas in COVID-19 pneumonia
    Gonzalez-Castro, Alejandro
    Campoverde, Aurio Fajardo
    Roncalli, Angello
    MEDICINA CLINICA, 2022, 159 (08): : E53 - E53
  • [24] Use of almitrine in spontaneously breathing patients with COVID-19 treated with high-flow nasal cannula oxygen therapy and with persistent hypoxemia
    Clément Saccheri
    Lucas Morand
    Marie Juston
    Denis Doyen
    Hervé Hyvernat
    Romain Lombardi
    Raphaël Devanlay
    Émilie Panicucci
    Jean Dellamonica
    Mathieu Jozwiak
    Respiratory Research, 24
  • [25] Use of almitrine in spontaneously breathing patients with COVID-19 treated with high-flow nasal cannula oxygen therapy and with persistent hypoxemia
    Saccheri, Clement
    Morand, Lucas
    Juston, Marie
    Doyen, Denis
    Hyvernat, Herve
    Lombardi, Romain
    Devanlay, Raphael
    Panicucci, Emilie
    Dellamonica, Jean
    Jozwiak, Mathieu
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [26] Prolonged treatment of COVID-19 pneumonia with high-flow nasal oxygen: A story of oxygen and resilience
    Audley, G. G.
    Frankenfeld, P.
    Dlamini, S.
    Raubenheimer, P.
    Hoare, J.
    Cairncross, L.
    van den Berg, R.
    Gule, M., V
    Calligaro, G.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2020, 110 (12): : 1168 - 1171
  • [27] The application of an oxygen mask, without supplemental oxygen, improved oxygenation in patients with severe COVID-19 already treated with high-flow nasal cannula
    Besarta Dogani
    Fredrik Månsson
    Fredrik Resman
    Hannes Hartman
    Johan Tham
    Gustav Torisson
    Critical Care, 25
  • [28] The application of an oxygen mask, without supplemental oxygen, improved oxygenation in patients with severe COVID-19 already treated with high-flow nasal cannula
    Dogani, Besarta
    Mansson, Fredrik
    Resman, Fredrik
    Hartman, Hannes
    Tham, Johan
    Torisson, Gustav
    CRITICAL CARE, 2021, 25 (01)
  • [29] Experience with high-flow nasal oxygen therapy in COVID-19 patients on a regular internal medicine ward
    Hofer, Markus
    Schmiedskamp, Mark
    Rezek, Spencer
    Ott, Natalie
    Unger, Ines
    Volk, Georg
    Hetzel, Juergen
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [30] Prone positioning combined with high-flow nasal or conventional oxygen therapy in severe Covid-19 patients
    Cyrielle Despres
    Yannick Brunin
    Francis Berthier
    Sebastien Pili-Floury
    Guillaume Besch
    Critical Care, 24